The Use of Silica Coated MnO Nanoparticles to Control MRI Relaxivity in Response to Specific Physiological Changes

Biomaterials

Volumn 33, Issue 13, 2012, Pages 3560-3567

  Lee, Yi Cheng ^a   Chen, Der Yow ^b   Dodd, Stephen J ^b   Bouraoud, Nadia ^b   Koretsky, Alan P ^b   Krishnan, Kannan M ^a  

^a University of Washington   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Contrast agent; Manganese enhanced MRI; MnO nanoparticle; PH responsive

Indexed keywords

CELLULAR UPTAKE; CONTRAST AGENT; CORE-SHELL; CORE-SHELL NANOPARTICLES; IN-VITRO; LIVER CELLS; MANGANESE ENHANCED MRI; PH-RESPONSIVE; RAT BRAIN; RELAXIVITY; SURFACE RECEPTORS; TIME-DEPENDENT SIGNALS; TRACT-TRACING;

BIOLOGICAL ORGANS; COATINGS; MANGANESE; MOLECULAR BIOLOGY; NANOPARTICLES; SILICA; TISSUE;

MANGANESE OXIDE;

MANGANESE; MANGANESE OXIDE; MANGANESE OXIDE NANOPARTICLE; NANOPARTICLE; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISSOLUTION; DRUG COATING; ENDOCYTOSIS; ENDOSOME; GALLBLADDER; IN VITRO STUDY; LIVER CELL; LYSOSOME; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PH; PRIORITY JOURNAL; RAT; THALAMOCORTICAL TRACT;

ANIMALS; BRAIN; COATED MATERIALS, BIOCOMPATIBLE; ECHO-PLANAR IMAGING; FEMALE; HALF-LIFE; HYDROGEN-ION CONCENTRATION; INJECTIONS; MAGNETIC RESONANCE IMAGING; MALE; MANGANESE COMPOUNDS; MICE; NANOPARTICLES; OXIDES; PHYSIOLOGICAL PHENOMENA; RATS; RATS, SPRAGUE-DAWLEY; SILICON DIOXIDE; TAIL; TIME FACTORS;

RATTUS;

EID: 84862783721     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.01.062     Document Type: Article

References (27)

1. Lin Y.J., Koretsky A.P. Manganese ion enhances T1-weighted MRI during brain activation: an approach to direct imaging of brain function. Magn Reson Med 1997, 38:378-388.
2. Caravan P., Ellison J.J., McMurry T.J., Lauffer R.B. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev 1999, 99:2293-2352.
3. Louie A.Y., Huber M.M., Ahrens E.T., Rothbacher U., Moats R., Jacobs R.E., et al. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotech 2000, 18:321-325.
4. Li W.H., Fraser S.E., Meade T.J. A calcium-sensitive magnetic resonance imaging contrast agent. J Am Chem Soc 1999, 121:1413-1414.
5. Zhang S.R., Trokowski R., Sherry A.D. A paramagnetic CEST agent for imaging glucose by MRI. J Am Chem Soc 2003, 125:15288-15289.
6. Lelyveld V.S., Brustad E., Arnold F.H., Jasanoff A. Metal-substituted protein MRI contrast agents engineered for enhanced relaxivity and ligand sensitivity. J Am Chem Soc 2011, 133:649-651.
7. Krishnan K.M. Biomedical nanomagnetics: a spin through possibilities in imaging, diagnostics, and therapy. IEEE Trans Mag 2010, 46:2523-2558.
8. Park I.K., Ng C.P., Wang J., Chu B., Yuan C., Zhang S., et al. Determination of nanoparticle vehicle unpackaging by MR imaging of a T2 magnetic relaxation switch. Biomaterials 2008, 29:724-732.
9. Taktak S., Sosnovik D., Cima M.J., Weissfeder R., Josephson L. Multiparameter magnetic relaxation switch assays. Anal Chem 2007, 79:8863-8869.
10. Atanasijevic T., Shusteff M., Fam P., Jasanoff A. Calcium-sensitive MRI contrast agents based on superparamagnetic iron oxide nanoparticles and calmodulin. PNAS 2006, 103:14707-14712.
11. Koretsky A.P., Silva A.C. Manganese-enhanced magnetic resonance imaging (MEMRI). NMR Biomed 2004, 17:527-531.
12. Silva A.C., Lee J.H., Aoki L., Koretsky A.R. Manganese-enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations. NMR Biomed 2004, 17:532-543.
13. Tucciarone J., Chuang K.H., Dodd S.J., Silva A., Pelled G., Koretsky A.P. Layer specific tracing of corticocortical and thalamocortical connectivity in the rodent using manganese enhanced MRI. Neuroimage 2009, 44:923-931.
14. Hu T.C.C., Christian T.F., Aletras A.H., Taylor J.L., Koretsky A.P., Arai A.E. Manganese enhanced magnetic resonance imaging of normal and ischemic canine heart. Magn Reson Med 2005, 54:196-200.
15. Leoni L., Serai S.D., Magin R.L., Roman B.B. Functional MRI characterization of isolated human islet activation. NMR Biomed 2010, 23:1158-1165.
16. Na H.B., Lee J.H., An K.J., Park Y.I., Park M., Lee I.S., et al. Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew Chem-Int Edit 2007, 46:5397-5401.
17. Shapiro E.M., Koretsky A.P. Convertible manganese contrast for molecular and cellular MRI. Magn Reson Med 2008, 60:265-269.
18. Bennewitz M.F., Lobo T.L., Nkansah M.K., Ulas G., Brudvig G.W., Shapiro E.M. Biocompatible and pH-sensitive PLGA encapsulated MnO nanocrystals for molecular and cellular MRI. ACS Nano 2011, 5:3438-3446.
19. Sotak C.H., Sharer K., Koretsky A.P. Manganese cell labeling of murine hepatocytes using manganese(III)-transferrin. Contrast Media Mol 2008, 3:95-105.
20. Kabanov A.V., Batrakova E.V., Alakhov V.Y. Pluronic((R)) block copolymers for overcoming drug resistance in cancer. Adv Drug Deliver Rev 2002, 54:759-779.
21. Lee Y.C., Pakhomov A.B., Krishnan K.M. Size-driven magnetic transitions in monodisperse MnO nanocrystals. J Appl Phys 2010, 107:09E124.
22. Chatterji T., Su Y.X., Iles G.N., Lee Y.C., Khandhar A.P., Krishnan K.M. Antiferromagnetic spin correlations in MnO nanoparticles. J Magn Magn Mater 2010, 322:3333-3336.
23. Park J., Kang E.A., Bae C.J., Park J.G., Noh H.J., Kim J.Y., et al. Synthesis, characterization, and magnetic properties of uniform-sized MnO nanospheres and nanorods. J Phys Chem B 2004, 108:13594-13598.
24. Gonzales M., Krishnan K.M. Synthesis of magnetoliposomes with monodisperse iron oxide nanocrystal cores for hyperthermia. J Magn Magn Mater 2005, 293:265-270.
25. Paxinos G., Waston C. The rat brain in stereotaxic coordinates 2005, Acdemic Press, San Diego (CA). 5th ed.
26. Tago T., Shibata Y., Hatsuta T., Miyajima K., Kishida M., Tashiro S., et al. Synthesis of silica-coated rhodium nanoparticles in reversed micellar solution. J Mater Sci 2002, 37:977-982.
27. Corot C., Robert P., Idee J.M., Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliver Rev 2006, 58:1471-1504.